Abstract
dc:description.abstractOBJECTIVE: Despite patterns observed during previous respiratory virus outbreaks, pediatric populations have been more likely than their adult counterparts to display mild or no symptoms in response to infection by the SARS-CoV-2 virus. The exact reasons for this have yet to be fully determined - although there are several theories undergoing current research. Our study, however, focuses on the development of immunological memory in children in response to SARS-CoV-2 vaccination, particularly in T cells. We hypothesize that - following the first, second, and booster dose of the Moderna mRNA vaccine - there will be a clear increase in T cell marker activation in pediatric PBMC samples. METHODS: PBMCs were acquired from blood samples drawn from 15 pediatric participants following the administration of the first, second, and booster dose of the Moderna mRNA SARS-CoV-2 vaccine. For the purposes of our study, pediatric will be defined as 5 to 11 years of age. A T cell activation assay was then performed using the PBMCs from all 15 participants, where samples were either stimulated with the SARS-CoV-2 spike protein or left unstimulated for control. Both the stimulated and unstimulated control samples were then stained utilizing antibodies that labeled T cell-specific AIMs. The antibody-stained samples were run through a flow cytometer for analysis. Finally, results were analyzed using either a two-way or one-way ANOVA. RESULTS: Following the completed series of Moderna mRNA SARS-CoV-2 vaccination (first, second, and booster doses), there was an increase in CD4+ T cell AIM expression in children. CD8+ T cell AIM expression in children, however, remained unchanged following the completed vaccine series. Our results also demonstrated an increase in cytokine activity in CD4+ pediatric T cells after vaccination but a decrease in cytokine activity in CD8+ pediatric T cells after vaccination – although, neither of these findings were statistically significant. CONCLUSIONS: Our findings indicate a preference for the development and activation of CD4+ T cell AIMs over CD8+ T cell AIMs by the pediatric immune system in response to the SARS-CoV-2 virus and vaccine. These results suggest that the pediatric immune response to COVID-19 favors the establishment of tolerance as opposed to mounting a full, systemic inflammatory response. However, further research is needed to determine if this is a causal relationship or simply a correlation.
Degree
thesis:*- Name thesis:degree_name
- Master of Science
- Level thesis:degree_level
- masters
- Discipline thesis:degree_discipline
- Medical Sciences
- Grantor
- Boston University
- Year dc:date.issued
- 2023
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Miller, Jordan Alexis
- Advisors dc:contributor.advisor
-
- Gerstenfeld, Louis
- Jain, Nitya
Subjects
dc:subject × 1Rights
- Language dc:language.iso
- en_US
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- https://hdl.handle.net/2144/48341